Pilot / proof point

An early prototype of Klinovant is in clinical pilot use at Universitätsmedizin Mannheim (UMM).Two department heads are actively involved in the trial.

The pilot demonstrates technical feasibility of the approach in a real clinical work environment — it does not demonstrate clinical efficacy or a treatment outcome, and it does not substitute for a conformity assessment under the EU Medical Device Regulation (MDR).

Important note

Klinovant is not currently an approved medical device under the EU MDR. The pilot runs under physician oversight as a feasibility demonstration and does not establish the safety or effectiveness of a future certified product. See theregulatory roadmap for the path to CE marking.

What the pilot shows

The software can be integrated into a real clinical workflow.
Capture and structuring work under the hospital's own on-premise operation.
Physician review and approval remain part of the workflow throughout (human-in-the-loop).